Tutorials
Pyxis Oncology Inc logo

Pyxis Oncology Inc

$ 2.95 -0.02 (-0.67%) 10:08 PM EST
P/E:
At Loss
P/B:
0.40
Market Cap:
$ 96.81M
Enterprise V:
$ -177.10M
Volume:
14.28K
Avg Vol (2M):
150.59K
Volume:
14.28K
Market Cap $:
96.81M
PE Ratio:
At Loss
Avg Vol (2-Month):
150.59K
Enterprise Value $:
-177.10M
PB Ratio:
0.40
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Pyxis Oncology Inc
NAICS : 325412 SIC : 2834
35 CambridgePark Drive, Cambridge, MA, USA, 02140
Description
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.92
Interest Coverage No Debt
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 73.11
9-Day RSI 66.07
14-Day RSI 61.92
6-1 Month Momentum % -65.5

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 13.1
Quick Ratio 13.1
Cash Ratio 12.88

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-08-15 Est.)

PYXS's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:PYXS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -2.196
Beta 0
Volatility % 0
14-Day RSI 61.92
14-Day ATR ($) 0.1705
20-Day SMA ($) 2.7895
12-1 Month Momentum % 0
52-Week Range ($) 1.96 - 19
Shares Outstanding (Mil) 32.82

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pyxis Oncology Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More